Immediate Impact

1 by Nobel laureates 1 from Science/Nature 63 standout
Sub-graph 1 of 24

Citing Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Hot and cold tumors: Immunological features and the therapeutic strategies
2023 Standout
2 intermediate papers

Works of J. Huober being referenced

Abstract P6-16-01: Health-related quality of life in MONARCH 3: Abemaciclib plus an aromatase inhibitor as initial therapy in women with HR+, HER2- advanced breast cancer
2019
Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
2008

Author Peers

Author Last Decade Papers Cites
J. Huober 212 199 33 83 21 316
Maria Elena Jacomuzzi 200 106 37 69 17 356
Olivier Brouckaert 223 196 53 139 24 368
Rita Ceccherini 179 163 43 50 15 267
Lamar Eaton 113 177 41 94 12 273
Chan Seok Yoon 156 191 39 96 18 352
Nicoletta Provinciali 171 118 51 37 22 298
Mitsugu Yamamoto 247 144 88 52 12 330
C. Brumm 153 85 32 48 18 328
D. Crawford 132 169 44 97 18 328
Bernhard Suchy 196 111 71 63 14 312

All Works

Loading papers...

Rankless by CCL
2026